Or Refractory Aggressive B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Or Refractory Aggressive B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas [Phase 1, Phase 2]
Phase 1/2 trial results evaluate MEDI-551 (inebilizumab) in combination with immunomodulating therapies for relapsed or refractory aggressiv…